SOLARA

Solara Active Pharma Sciences Shareholding Pattern

₹647.70-1.10%close, 9 Oct 2026
Market cap
₹3,120 crore
P/E
22.5
P/B
2.85
ROE
14.5%
Dividend yield
1.20%
52-week range
₹466.34 – ₹874.40

As of Jun 2026, promoters held 48.50% of Solara Active Pharma Sciences, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.

Solara Active Pharma Sciences shareholding pattern

Percentage of shares held, by quarter, newest first.

Solara Active Pharma Sciences shareholding by category (% of equity)
HolderJun 2026
Promoters48.50%
Foreign institutions (FII/FPI)18.40%
Domestic institutions (DII)14.20%
of which mutual funds8.50%
Government0.00%
Public18.90%
Others2.10%

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.

Solara Active Pharma Sciences shareholding pattern — frequently asked questions

What is the promoter holding in Solara Active Pharma Sciences?

Promoters held 48.50% of Solara Active Pharma Sciences as of Jun 2026.

How much do FIIs hold in Solara Active Pharma Sciences?

Foreign institutional investors held 18.40% of Solara Active Pharma Sciences as of Jun 2026.

How much do domestic institutions hold in Solara Active Pharma Sciences?

Domestic institutional investors, including mutual funds and insurers, held 14.20% of Solara Active Pharma Sciences as of Jun 2026; mutual funds alone held 8.50%.

Who owns Solara Active Pharma Sciences?

As of Jun 2026, Solara Active Pharma Sciences' shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.

Same Data For Peers

💡 LearnHow to read a shareholding pattern →

Trade Solara Active Pharma Sciences With ATS

Track SOLARA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Solara Active Pharma Sciences share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.